AURA 2021

  31 August 2021

Antimicrobial resistance (AMR) continues to be one of the most significant challenges that healthcare services face in Australia, and around the world. The Antimicrobial Use and Resistance in Australia (AURA) Surveillance System collects, reviews and analyses AMR and antimicrobial use (AU) data, monitoring patterns and trends, and regularly reporting on AU and AMR across Australia. Local and national data on AMR and AU are available for all levels of the Australian healthcare system, across the acute care and community sectors, and for the public and private sectors.

AURA 2021 is the fourth in a series of national reports developed by the Australian Commission on Safety and Quality in Health Care (the Commission) to enhance AMR prevention and containment strategies. These reports and the data captured through the AURA Surveillance System support effective clinical practice, policy decisions, and prioritisation of public health action.

Author(s): Australian Commission on Safety and Quality in Healthcare
Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support kindly provided by

Antimicrobial Resistance Fighter Coalition

CDD VAULT Complexity Simplified





Technology Database

Display your AMR Technology, Product and Service

Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.

Read more and make your own Technology Page >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!